印度胰島素幫浦市場評估：依類型、依產品、依配件、依適應症、依年齡層、依最終用戶、依分銷管道、依地區、機會、預測（2017 財年-2031 財年）

2023 財年，印度胰島素幫浦市場規模為 3,180 萬美元，預計到 2031 財年將達到 6,063 萬美元，2024 財年至 2031 財年預測期間複合年增長率為 8.4%。該市場受到糖尿病患病率上升、對優先考慮便利性和易用性的胰島素輸送設備的需求增加、技術進步、政府舉措、老年人口增長以及醫療費用上漲等因素的推動。

印度胰島素幫浦市場在醫療領域佔據中心地位，預計將大幅擴張和發展。隨著糖尿病盛行率持續上升，對先進糖尿病管理解決方案的需求變得更加迫切。在此背景下，印度胰島素幫浦市場已成為技術創新的先驅，為那些尋求更好的血糖調節方法和管理糖尿病管理複雜性的人們帶來了希望。這些設備具有以最少的努力提供準確的胰島素劑量的獨特優勢，使其成為糖尿病管理的寶貴資產。

政府減輕糖尿病負擔和降低醫療費用的努力正在推動印度胰島素幫浦市場的擴張。提倡採用先進糖尿病管理技術的公共衛生舉措和政策改善了胰島素幫浦的取得和可用性，使廣大印度人口受益。此外，印度人口老化也是推動胰島素幫浦市場擴張的主要因素。容易患糖尿病的老年人需要有效的胰島素管理解決方案。在此背景下，印度胰島素幫浦市場成為樂觀的源泉，為希望改善糖尿病控制從而提高生活品質的人們提供了一種創新且易於使用的選擇。

認知度的提高推動市場成長

印度胰島素幫浦意識的迅速提高正在對市場產生積極影響。糖尿病患者越來越認識到胰島素幫浦的好處，包括增強血糖控制和降低低血糖風險。這種日益增長的意識正在推動對胰島素幫浦的需求並推動市場擴張。此外，印度糖尿病協會等組織在提高人們對胰島素幫浦的認識、消除相關誤解以及努力提高糖尿病患者的可用性和可及性方面發揮著重要作用。隨著人們對胰島素幫浦的認識不斷提高，這些設備的印度市場預計將擴大，為胰島素幫浦開發商和製造商創造機會。

印度老年人口成長

由於人口老化，印度的胰島素幫浦市場正在經歷重大轉型。在老年人口迅速膨脹的印度，該年齡層糖尿病尤其是第2型糖尿病的盛行率顯著上升。因此，作為有效糖尿病管理的重要工具，對胰島素幫浦的需求顯著增加。老齡化人口對糖尿病的脆弱性強調了精確控制胰島素的必要性。這些人口變化正在顯著改變醫療保健格局，尤其是印度的糖尿病照護。人口老化是罹患糖尿病的高風險。這是由於體力活動減少和肥胖增加等因素所造成的。糖尿病盛行率的增加促使對胰島素幫浦的需求增加。

政府措施

政府措施在塑造印度胰島素幫浦市場方面發揮關鍵作用。印度政府推出了各種政策、計劃和補貼，以改善胰島素幫浦和糖尿病管理技術的可近性，特別是針對經濟弱勢群體。

例如，2023 年 5 月，州政府宣佈打算向第 1 型糖尿病患者提供免費胰島素幫浦。胰島素幫浦價格昂貴，對於經濟困難的患者來說難以負擔。因此，如果沒有泵，這些患者就會依賴每天注射胰島素，並且更容易受到影響腎臟等重要器官的嚴重感染。

本報告研究和分析了印度胰島素幫浦市場，提供市場規模和預測、市場動態、主要參與者的現狀和前景等。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章 COVID-19 對印度胰島素幫浦市場的影響

第 4 章執行摘要

第五章印度胰島素幫浦市場展望（2017財政年度-2031財政年度）

• 市場規模與預測
  • 金額
  • 數量
• 依類型
  • 獨立胰島素幫浦
  • 內建感測器的胰島素泵
• 依產品
  • 泵
  • 消耗品
• 依配件
  • 胰島素儲液器、藥筒
  • 胰島素套件插入裝置
  • 電池
• 依指示
  • 1 型糖尿病
  • 2 型糖尿病
• 依年齡
  • 成人
  • 兒童
  • 雙重用途
• 依最終用戶
  • 醫院
  • 診所
  • 首頁
  • 實驗室
• 依分銷管道
  • 零售店
  • 醫院藥房
  • 電子商務
• 依地區
  • 北
  • 南部
  • 東方
  • 西部和中部地區
• 市佔率：依公司劃分（2023 財年）

第 6 章市場地圖（2023 財年）

• 依類型
• 依產品
• 依配件
• 依指示
• 依年齡
• 依最終用戶
• 依分銷管道
• 依地區

第七章宏觀環境與產業結構

• 需求與供給分析
• 進出口分析
• 價值鏈分析
• PESTEL 分析
• 波特五力分析

第 8 章市場動態

• 生長促進因素
• 抑製成長的因素（問題、限制因素）

第 9 章監理架構與創新

• 臨床試驗
• 專利情況
• 監理機關的核准
• 創新/新技術

第十章主要公司狀況

• 前 5 名市場領導者的競爭矩陣
• 前 5 位市場領導者的市場收入分析（2023 財年）
• 併購/合資企業（如果適用）
• SWOT 分析（5 家市場公司）
• 專利分析（如果適用）

第11章價格分析

第 12 章案例研究

第十三章主要公司展望

• India Medtronic Pvt. Ltd.
• Agva Healthcare Pvt. Ltd.
• Ypsomed India Pvt. Ltd.
• Tandem Diabetes Care, Inc.

第14章戰略建議

第十五章關於我們公司，免責聲明

India insulin pumps market size was valued at USD 31.8 million in FY2023, which is expected to reach USD 60.63 million in FY2031, with a CAGR of 8.4% for the forecast period between FY2024 and FY2031. India insulin pumps market is being driven by factors including the rising prevalence of diabetes, increasing demand for insulin delivery devices that prioritize convenience and user-friendliness, technological advancements, government initiatives, growing elderly population, and increasing healthcare expenditure.

India insulin pumps market holds a central position in the healthcare arena and is poised for significant expansion and evolution. As prevalence of diabetes continue to rise, the need for advanced diabetes management solutions becomes more serious. In this context, the insulin pumps market in India stands as a pioneer of innovation, providing hope for individuals navigating the complexities of diabetes management for seeking enhanced methods of blood glucose regulation. These devices offer the distinct advantage of delivering precise insulin doses with minimal effort, rendering them invaluable assets in the realm of diabetes management.

Government efforts to alleviate the diabetes burden and reduce healthcare expenses are driving the expansion of India insulin pumps market. Public health initiatives and policies advocating the adoption of advanced diabetes management technologies have improved insulin pump accessibility and affordability, benefiting a wider cross-section of the Indian populace. Moreover, India's aging demographics is a key factor in the growing insulin pumps market. The elderly population, prone to diabetes, requires efficient insulin management solutions. In this context, the India insulin pumps market emerges as a source of optimism, presenting innovative and accessible choices for individuals striving to achieve improved diabetes control and ultimately enhancing their quality of life.

Heightened Awareness is Propelling Market Growth

The surging awareness of insulin pumps in India is exerting a favourable influence on the India insulin pumps market. Individuals with diabetes increasingly recognize the advantages of insulin pumps, including enhanced blood sugar management and reduced hypoglycaemia risk. This heightened awareness is driving the demand for insulin pumps, fostering market expansion. Additionally, organizations such as the Indian Diabetes Association are playing a crucial role in rising awareness about insulin pumps, dispelling associated misconceptions, and striving to enhance affordability and accessibility for individuals with diabetes. As awareness of insulin pumps continues to rise, the Indian market for these devices is anticipated to expand, creating opportunities for insulin pump developers and manufacturers.

Increasing India's Ageing Population

India insulin pumps market is experiencing a notable transformation driven by the country's aging demographics. With a swiftly expanding elderly population, India is encountering a remarkable increase in the incidence of diabetes, notably Type 2 diabetes, within this age cohort. Consequently, there has been a substantial rise in the demand for insulin pumps as a pivotal instrument for effective diabetes management. The elderly demographic's inherent vulnerability to diabetes underscores the vital necessity for precise insulin control. This demographic shift is reshaping the healthcare landscape, particularly in the context of diabetes care in India. The ageing population is at a higher risk of developing diabetes. It is due to several factors, including the decline in physical activity and the increase in obesity. The increasing prevalence of diabetes is leading to an increased demand for insulin pumps.

Government Initiatives

Government actions are instrumental in shaping the India insulin pumps market. The Indian government has introduced a range of policies, programs, and subsidies to enhance access to insulin pumps and diabetes management technologies, especially for economically challenged individuals. This essay delves into the diverse facets in India, encompassing aspects, like accessibility, affordability, and the advancement of diabetes care technology, driven by the recognition of the growing diabetes burden.

As an example, in May 2023, the state government declared its intention to furnish complimentary insulin pumps to individuals with Type-1 diabetes. Given the substantial expense associated with insulin pumps, those hailing from economically challenged backgrounds find them financially inaccessible. Consequently, in the absence of these pumps, these patients resort to daily insulin injections, which elevates their susceptibility to severe infections affecting vital organs, such as the kidneys.

Rising Demand for Integrated Insulin Pumps

The India insulin pumps market is undergoing a significant evolution due to the introduction of integrated insulin pumps. This revolutionary technology merges insulin administration with continuous glucose monitoring (CGM), promising to revolutionize diabetes management. Integrated systems have the potential to redefine the way diabetes is controlled by offering real-time glucose data and automated insulin delivery, creating a seamless and highly precise method for managing blood sugar levels. The integrated insulin pumps are experiencing heightened demand owing to their capacity to improve blood sugar regulation and lower the risk of hypoglycaemia. As competition intensifies within the market, it is anticipated that the prices of integrated insulin pumps will decrease. The cost reduction will enhance affordability, making these devices more accessible to individuals managing diabetes.

Increasing Need for Insulin Pumps in Type 1 Diabetes

The rising need for solutions in Type 1 Diabetes has substantially led to the growth of India insulin pumps market. The demand for insulin pumps to manage Type 1 diabetes has witnessed a remarkable upswing, reflecting a pivotal shift in the realm of diabetes care. As Type 1 diabetes, an autoimmune condition characterized by insufficient insulin production, continues to affect millions worldwide, the need for advanced solutions to streamline insulin delivery and enhance glycaemic control has surged. For individuals, particularly youngsters, managing Type 1 diabetes, insulin pumps present a viable alternative. These devices can provide a consistent insulin supply, offering a reliable solution for those who may find it challenging to adhere to a strict schedule for insulin injections.

As an illustration, in March 2023, Medtronic unveiled the introduction of the MiniMed 780G system in the Indian market. This system, designed for individuals aged 7 to 80 years with type 1 diabetes, operates as a closed-loop insulin pump system. It harnesses Medtronic's SmartGuard technology to automate the administration of both basal insulin and correction boluses at five-minute intervals. This innovative approach assists individuals with diabetes in navigating their blood sugar levels with increased convenience, minimizing the occurrence of high and low glucose levels.

Impact of COVID-19

The COVID-19 pandemic had a twofold effect on the India insulin pumps market. It has negatively impacted the market due to disruptions in supply chains, limited access to healthcare facilities, and led to economic uncertainties. Import restrictions have resulted in shortages of insulin pumps and diabetes care products, hampering patient access to these devices. Additionally, reduced access to healthcare facilities has posed challenges for diabetes patients in receiving necessary care, including insulin pump therapy. Certain insurance providers have scaled back or entirely removed their coverage for insulin pumps, rendering them less accessible for individuals managing diabetes. However, the pandemic has increased awareness of managing chronic conditions like diabetes, potentially driving demand for insulin pumps. To ensure patient access to essential care and devices, market stakeholders must adapt to the evolving pandemic conditions.

Key Players Landscape and Outlook

The insulin pumps market in India is currently undergoing a significant shift with the rise of new entrants who are redefining the competitive terrain. Historically dominated by well-established healthcare companies, this market is now embracing innovative newcomers who bring fresh insights and state-of-the-art solutions. These emerging players are infusing dynamism into the industry by introducing novel technologies, promoting robust competition, and, most crucially, broadening the reach and affordability of insulin pumps to a wider cross-section of the Indian population.

In the realm of insulin pumps, Indian startups are leading the charge in innovation, reshaping the diabetes management landscape. Amid the growing prevalence of diabetes, these entrepreneurial ventures are leveraging their creativity to craft inventive solutions tailored to the specific requirements of diabetes management in India. For instance, in May 2023, Open MedLabs, an Indian startup, revealed its work on "InsuFlo," an open-loop insulin pump designed to be cost-effective for type-1 diabetic patients in resource-limited settings. The device has reached the prototype phase, demonstrating clinically precise insulin delivery. An upcoming animal study is planned. Ongoing efforts aim to elevate the device's Technology Readiness Level (TRL) and minimize its size to match competitors.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of Covid-19 on India Insulin Pumps Market

4. Executive Summary

5. India Insulin Pumps Market Outlook, FY2017-FY2031

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Type
  • 5.2.1. Standalone Insulin Pumps
  • 5.2.2. Sensor Integrated Insulin Pumps
• 5.3. By Product
  • 5.3.1. Pumps
    • 5.3.1.1. Tethered Pumps
    • 5.3.1.2. Patch Pumps
    • 5.3.1.3. Others
  • 5.3.2. Consumables
• 5.4. By Accessories
  • 5.4.1. Insulin Reservoir or Cartridges
  • 5.4.2. Insulin Set Insertion Devices
  • 5.4.3. Battery
• 5.5. By Disease Indication
  • 5.5.1. Type 1 Diabetes
  • 5.5.2. Type 2 Diabetes
• 5.6. By Age Group
  • 5.6.1 Adult
  • 5.6.2. Paediatrics
  • 5.6.3. Both
• 5.7. By End-user
  • 5.7.1. Hospitals
  • 5.7.2. Clinics
  • 5.7.3. Homeware
  • 5.7.4. Laboratories
• 5.8. By Distribution Channel
  • 5.6.1 Retail Stores
  • 5.6.2 Hospital Pharmacy
  • 5.6.3 E-commerce
• 5.9. By Region
  • 5.9.1. North
  • 5.9.2. South
  • 5.9.3. East
  • 5.9.4. West and Central
• 5.10. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

• 6.1. By Type
• 6.2. By Product
• 6.3. By Accessories
• 6.4. By Disease Indication
• 6.5. By Age Group
• 6.6. By End-user
• 6.7. By Distribution Channel
• 6.8. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 10.1 Clinical Trials
• 10.2 Patent Landscape
• 10.3 Regulatory Approvals
• 10.4 Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. India Medtronic Pvt. Ltd.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Agva Healthcare Pvt. Ltd.
• 13.3. Ypsomed India Pvt. Ltd.
• 13.4. Tandem Diabetes Care, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Insulin Pumps Market, By Value, In USD Billion, FY2017-FY2031F
• Figure 2. India Insulin Pumps Market, By Volume, In Units, FY2017-FY2031F
• Figure 3. India Insulin Pumps Market Share (%), By Type, FY2017-FY2031F
• Figure 4. India Insulin Pumps Market Share (%), By Product, FY2017-FY2031F
• Figure 5. India Insulin Pumps Market Share (%), By Accessories, FY2017-FY2031F
• Figure 6. India Insulin Pumps Market Share (%), By Disease Indication, FY2017-FY2031F
• Figure 7. India Insulin Pumps Market Share (%), By Age Group, FY2017-FY2031F
• Figure 8. India Insulin Pumps Market Share (%), By End-user, FY2017-FY2031F
• Figure 9. India Insulin Pumps Market Share (%), By Distribution Channel, FY2017-FY2031F
• Figure 10. India Insulin Pumps Market Share (%), By Region, FY2017-FY2031F
• Figure 11. By Type Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 12. By Product Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 13. By Accessories Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 14. By Disease Indication Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 15. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 16. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 17. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 18. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2023